Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia

Prenatal Diagnosis

Volumn 30, Issue 11, 2010, Pages 1026-1031

  Sifakis, Stavros ^a   Akolekar, Ranjit ^b   Kappou, Dimitra ^a   Mantas, Nikitas ^b   Nicolaides, Kypros H ^b,c  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; Insulin resistance; Insulin like growth factor I; Preeclampsia; Pregnancy; Uterine artery Doppler

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSATILE FLOW; UNPLANNED PREGNANCY; UTERINE ARTERY;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; PULSATILE FLOW; STATISTICS, NONPARAMETRIC; UTERINE ARTERY; YOUNG ADULT;

EID: 77958608877     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2555     Document Type: Article

References (40)

1. ACOG Committee. 2002. Diagnosis and management of preeclampsia and eclampsia. 2002. ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin, Number 33, Obstet Gynecol 99: 159-167.
2. Altinkaynak K, Aksoy HH, Bakan E, Kumtepe Y. 2003. Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsia. Clin Biochem 36: 221-223.
3. -Aplin JD, Lacey H, Haigh T, Jones CJ, Chen CP, Westwood M. 2000. Growth factor-extracellular matrix synergy in the control of trophoblast invasion. Biochem Soc Trans 28: 199-202.
4. Bartha JL, Romero-Carmona R, Torrejon-Cardoso R, Comino-Delgado R. 2002. Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am J Obstet Gynecol 187: 735-740.
5. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. 2001. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: IX-XIV.
6. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J. 2000. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulindependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab 85: 1518-1524.
7. D'Anna R, Baviera G, Corrado F, et al. 2006. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 113: 1264-1269.
8. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. 2006. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 113: 580-589.
9. Forbes K, Westwood M. 2008. The IGF axis and placental function. Horm Res 69: 129-137.
10. Fowler DJ, Nicolaides KH, Miell JP. 2000. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum Reprod Update 6: 495-504.
11. Friedman SA, Taylor RN, Roberts JM. 1991. Pathophysiology of preeclampsia. Clin Perinatol 18: 661-682.
12. Grobman WA, Kazer RR. 2001. Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet Gynecol 97: 521-526.
13. Guidice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. 1997. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 176: 751-757.
14. Halhali A, Bourges H, Carrillo A, Garabedian M. 1995. Lower circulating insulin-like growth factor I and 1, 25-dihydroxyvitamin D levels in preeclampsia. Rev Invest Clin 47: 259-266.
15. Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M, Larrea F. 2000. Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1, 25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 85: 1828-1833.
16. Han VK, Bassett N, Walton J, Challis JR. 1996. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 81: 2680-2693.
17. Högberg U. 2005. The World Health Report 2005: "make every mother and child count"-including Africans. Scand J Public Health 33: 409-411.
18. Hübinette A, Lichtenstein P, Brismar K, et al. 2003. Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 82: 1004-1009.
19. Ingec M, Gursoy HG, Yildiz L, Kumtepe Y, Kadanali S. 2004. Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. Int J Gynaecol Obstet 84: 214-219.
20. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. 1995. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 85: 353-356.
21. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. 2008. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 31: 618-624.
22. Kazer RR. 2003. A hypothesis for altered activity of insulin-like growth factor I in women with pre-eclampsia. Int J Gynecol Obstet 80: 173-174.
23. Khong TY, De Wolf F, Robertson WB, Brosens I. 1986. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. BJOG 93: 1049-1059.
24. Kocyigit Y, Bayhan G, Atamer A, Atamer Y. 2004. Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance. Gynecol Endocrinol 18: 341-348.
25. Lacey H, Haigh T, Westwood M, Aplin JD. 2002. Mesenchymally-derived insulin-like growth factor 1 provides a paracrine stimulus for trophoblast migration. BMC Dev Biol 2: 5.
26. Lewitt MS, Scott FP, Clarke NM, Wu T, Sinosich MJ, Baxter RC. 1998. Regulation of insulin-like growth factor-binding protein-3 ternary complex formation in pregnancy. J Endocrinol 159: 265-274.
27. Lorentzen B, Birkeland KI, Endresen MJ, Henriksen T. 1998. Glucose intolerance in women with pre-eclampsia. Acta Obstet Gynecol 77: 22-27.
28. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. 1994. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. BJOG 101: 669-674.
29. Milio LA, Hu J, Douglas GC. 1994. Binding of insulin-like growth factor I to human trophoblast cells during differentiation in vitro. Placenta 15: 641-651.
30. Monzavi R, Cohen P. 2002. IGFs and IGFBPs: role in health and disease. Best Pract Res Clin Endocrinol Metab 16: 433-447.
31. Ning Y, Williams MA, Vadachkoria S, Muy-Rivera M, Frederick IO, Luthy DA. 2004. Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia. Clin Biochem 37: 968-973.
32. Olausson H, Lof M, Brismar K, Lewitt M, Forsum E, Sohlstrom A. 2008. Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. Horm Res 69: 99-106.
33. Plascencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. 2007. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30: 742-749.
34. Poon LCY, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. 2009. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks. Ultrasound Obstet Gynecol 34: 142-148.
35. Randhawa R, Cohen P. 2005. The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 86: 84-90.
36. Smith S, Francis R, Guilbert L, Baker PN. 2002. Growth factor rescue of cytokine mediated trophoblast apoptosis. Placenta 23: 322-330.
37. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 352: 343-346.
38. Sowers M, Scholl T, Grewal J, Chen X, Jannausch M. 2001. IGF-I, osteocalcin, and bone change in pregnant normotensive and pre-eclamptic women. J Clin Endocrinol Metab 86: 5898-5903.
39. Vatten LJ, Skjaerven R. 2004. Is pre-eclampsia more than one disease? BJOG 111: 298-302.
40. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. 2005. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 193: 429-436.